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<SUMMARY ' -lepurpose of this research is to investigate the properties of receptors for excitatory neurotransmitters in the central nervous system (CNS), particularly those for acidic amino acids and related derivatives. Most of the synapses in the CNS appear to use these molecules as neurotransmitters but little is known about their receptor properties. Various phosphonic acid derivatives and toxins appear to act directly or indirectly on these receptors. This research uses a newly developed anatomical method to localize the various receptor subtypes in the rodent brain. Electrophysiological analysis is used to record the physiological response to various agonists and antagonists that act on these receptors.
"Our results have shown, for the first time, that glutamate receptors are most concentrated in the cerebral cortex and hippocampus in addition to key pathways from the peripheral to the CNS. Electrophysiological analysis indicates that select antagonists (e.g., 2-amino-4-phosphonobutyrlc acid) will block synaptic transmission at some pathways, while other antagonists in this series (e.g., 2-amino-5-phosphonopentanole acid) will block a type of synaptic short-term memory at other pathways without interfering with normal synaptic transmission, These compounds are thus highly selective in their mode of action --*Other new antagonists related to piperazine-2,3-dicarboxylic acid are more general ntagonists blocking synaptic transmission at most hippocampal pathways, though they e not aa potent. ' :
IORE WORD
In conducting the research described in this report, the investigator adhered to the "Guide for the Care 
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BACKGROUND It now appears that the acidic amino acids glutamate and/or Rspartate serve as the major excitatory neurotransmitters In the central nervous system (CNS). These transmitters certainly play a major role in brain and spinal cord function, mediating the inflow of information from the periphery and the processing and transformation of signals within the CNS prior to motor output via choeinergic pathways. Much is known about the structure-activity relationships of cholnergic synaptic transmission but very little is known about these relationships for the main excitatory pathways in the CNS. Compounds including phophonate derivates and several neurotoxins are active at such receptors, emphasizing the needs for better data on receptor properties. The goal of our work over the past year has been to define the types of acidic amino acid receptors that mediate synaptic transmission at various excitatory pathways in the CNS.
There appear to be at least four different classes of receptors for acidic amino acids that are best characterized by their selective interaction with different acidic amino acid analogues. These aire the N-methyl-D-aspartate (NMDA) site, the quisqualate (QA) site, the kainate (KA) site, and the L-+)-2-amino-4-phosphonobutyric acid (L-APB) site (1, 2) . We have localized several of the receptor subtypes in the rndent brain using a newly developed autoradiographic method(3), and studied the electrophysiological properties of NMDA and L-APB receptors primarily in the hippocampus.
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L. fpEge. of L-APO Reorts In the ft oesmt"
Previously we reported that b-APB is a potent antagonist at the lateeal perforant path in the rodent hippocampus (4) . Others subsequently showed that L-APB also acted on components of the monogynaptic pathway of the spinal cord and the rod-bipolar synapses in the rabbit (S,8) . At present L-APB is the most potent antagonist available for excitatory pathways In the CNS. We also began to explore the development of other antagonists active at this receptor, Including serine-O-phosphate (SOP). SOP will selectively d~sczininate between bmin and spinal cord receptors in that it is relatively impotent at the spinale cord but is acUve in the brain. We also reported recently that Ls-
5.
APB acts on hippocampal pathways in a species-specific manner(7). The acidic amino acid antagonist DL-APB is a potent blocker of synaptic transmission at guinea pig but not rat mossy fiber-CA3 synapses in hippocampal slices. The L-isomer of APB is responsible for the potent inhibition at the guinea pig synapse. The L-APB analogue L-SOP also is more potent against the guinea pig response. These differences may reflect a difference in a synaptic acidic amino acid receptor in these two species. Other acidic amino acid antagonists are less potent than L-APB or L-SOP and do not discriminate between the mossy fiber responses in the two species. Thus, L-APB appears to be an interesting and highly specific antagonist for CNS pathways. At present, the site of action of L-APB is unknown. It may work presynaptically, postsynaptically, or both. It is reasonably clear that it does not work as a conventional postsynaptic antagonist. Most evidence, such as that cited below, favors a novel presynaptic locus of action, possibly involving chloride ions. Work is still in progress on the mechanism of action. We have used radioligand lIndlng techniques to determine the anatomical distribution of NMDA-displaceable lH-L-glutamate binding sites in rat brains. Young adult (45-60 day) male and female Sprague-Dawley rats were sacrificed by decapitation, and 6i-thick brain sections were sliced on a freezing cryostat for quantitative autoradiography, as previously described(3). The highest concentrations are found in the outer layers of cerebral cortex, pyriform cortex, anterior olfactory nuclei, nucleus accumbens, and stratum radiatum and stratum oriens of hippoanampus (see Fig. 1 ). High levels are found within the caudate/putamen, middle and deep cerebral cortical le,,ers, nucleus retniens, lateral septum and external plexiform layer of the olfactory bulb. Moderate levels are found in thalamus, granule cell layer of the cerebellum, inferior olive, medial vestibular nucleus, nucleus solitary tract, cuneate nucleus, dorsal cochlear nucleus, dorsal horn of spinal cord, and medial septum. Low levels are found In the globus palliduvs habenulat hypothalamus, midbrain, and the rooleclaW layer of the cerebellumn(8).
W•e have used extracellular and intracellular analyses of the excitations produced by several amino acid agonists to characterize the electrophystologalcl respoise in hippotampal area CAI, one of those regions containing the highest concentration of NMDA receptors in the brain. Previously we examined the relative potency of various agonists on CAI pyramidal neurons (9) . The relative potency of analogues of excitatory amino acids to produce depolarization when applied in the apical dendritic field of CAI cells was stud!ed in the hippocampal slice. The effect of these compounds was measured by recording focal potentials (FPs), the shift in the extraceliular d.c. potential produced by the compounds applied. The ability of FPs to measure neuronal responses was evaiuated. NMDA-typo agonists were 10-20 times more potent. relative to L-giutamate, than reported from investigations in spinal cord. QA, i a-amino-3-hydroxy-5-tnethyl-4-isoazoleproplonic acid (AMPA) and KA exhibited potencies on CAI cells similar to those reported for spinal neurons. These data indicate that elements in CAI eells possess a receptor with an affinity for NMDA-type agonists.
We have examined several endogenous agonistst Including quinolinic acid, S-Sulpho-l-cysteine, and L-homooysteine sulfinate. These compounds, as well as the potent excitants NMDA and ibotanic acid, produce burst firing of sodium action potentials, tetrodotoxin-resistant recurrent spikes and apparent increases in input resistance. These excitants also show the profile mentioned above for antagonism by phosphono amino acids. Thus, it appears to be possible to differentiate NMDA-type agonists from other excitant amino acids by physiological as well as pharmacological criteria. Other agonists, including glutamate, QA4 and KA do not elicit the responses listed above. The latter compounds elicit steady 6. ?'F _ Distribution of NMDA-lisplaceable 3 lH-lutamate binding sites in a horizontal section of a rat brain. The light areas correspond to maximal binding sites. Note that the heaviest labeling is found in the outer layers. of the cerebral cortex and the hippocampus. Abbreviations, upper panel: C, eingulate cortex; C8, cerebellum, Cg, central gray; CU, eaudate putamen; B, entorhainal cortex; Ffrontal cortex; li, hippocampus; L, lateral geniculate; M medial genieulate; MB, mammillary body; OB, Solfactory bulb; P, parietal cortex; S, septum; T. temporal cortex; Tb, thalamus. '4* firing and decreases in input resistance; these compounds are also resistant to inhibition by phosphono amino acids. These data suggest that NMDA receptors play a special role in the hippocampus.
Recently there has been speculation that aspartate-or glutamate-containing dipeptides are excitatory neurotranmmitters in the hippocampus. The dipeptide N-acetylaspartylglutamate (NAAG) has been found in high concentrations in rat brain and has been reported to bind to glutamate receptors(iO). Further, it has been reported that excitations produced by NAAG in the rat olfactory cortex are selectively blocked by L-APB(Il). However, our preliminary experiments with NAAG in the hippocampal slices indicate that this compound does not have excitatory actions on hippocampal neurons. Further work will be required to clarify the actions of this endogenous excitant in the hippocampus and other CNS structures.
3. Nature of the Receptor bydolved In S• t.e , mmudim
Gur results and those of others suggest that synaptic receptors in the hippocampus may be of the KA or the QA type, while other receptor. te o the L-APB or the NMDA type. Compounds such as GDEE (gamma-D-outamyl glyolne) and D(4-2-amino-5-phosphono-pentanoic amd (D-AP5; also referred to as-D-APV or -AP5) which are potent antagonists of epplied axcitatory amino aeids (12) are rather poow blockers of CNS synaptic transmmsion(l,2,13). Pvevlowly we discovehed that the naturally o-euring compound kynuranlc acid b an effective, though only moderately potent, antagonist in the hippoeampus (14) . Work is in pr•gres using newly snftheslzed compounds to search for drugp that will prove to be more potent antagoists of these receptors, and will thereby aid in differentiating between these varlow receptor classes.
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Recently (15), we examined the effects of a new series of compoutds, piperazine-2,3-4icarboxylle acid (PzDA) derivatives, on excitatory synaptic tran•mission in hippocampel slices. These compounds have been shown (16) to be potent antagonists of applied excitatory amino acids and provide a se,-ties of structurally-related comounds useful for examining structure-activity relationships. We examined the effects of these compounds on the pathway from hippocampel region CA3 to region CAI (the Schaffer-colUateralcommissural pathway) in slices obtained from young adult male Sprague-Dawley rats using standard procedures as described previously (4, 7, 9, 14) . Schaffer conaterals were stimulated electrically and evoked synaptic potentials were recorded extracetularly from region CA1. PzDA at 1mM inhibited the Schaffer collateral-commWurel synaptic The"e PzT')A derivatlve will be helpful for clarifying CtNS reteptors-in two ways. Firs-t, this saries of analogues. contains antag.nist of synaptit transmission with a wider range of potency than that previously available. Second' , several PzDA derivatives (2-CB-.PzDA and Lý-fBBPzDA) are the most potent acidic amino acid antagonists yet avakilable for the SehAf fer-C.U synaptic responseg a p4v~ty'pical pathway in thte CN& We have also examined the actions of the more potent antagonists on exeitatory neuro-* ~~trans-mLison at the other hippocampal p'-*tway~s (Pig. 3). Medial and lateral pefor. path respones and mossy fiber synaptic responses weft also inhibited by about 50% by ¶ ~0.0540.2 mM solutions of these two compounds.
Focal depoalarizatons induced by lonophoretic application of excitatory amino acift In stratum radiatum of field CAI were also antagonzed by solutions of N-LPCI3-PzDA and N-pj.8IB-PzDA. T'hese PzDA derivatives at 100U~1 solutions blocked INMDA responses by 60o40% but w"r less effective against KA and especially QA responses (IFig. 4).
The Timilar effect of PzDA analogues agtaist synaptic responses in different hippoeampeI pathweys may indicate that neurotranmmission in these pathways is mediated i~y similar excitatory amino acid receptors.
The weak depression of hlppoe-amnpel pathways by specific I4MDA antagonists indicates that the primary synaptic receptor 19 not of the INMDA class. Although agonist-inuced focal potentials and synoptic field potentials are difficult to compare quantitativelyt the apparent gremter potency of PzDA analogues against synaptic compared with agonist-induced responses suggests the possibility of a posbsynaptlc receptor type not selectively activated by NMDAt KA9orQA.
•' 9. 'The normal function of ONS pathways involves the operation of plasticity mechanisms. A ubiquitous form of synaptic plasticity is elicited by stimulation with pairs of stimuli separated by 2&-400 milliseconds. Depending on the specific pathway, this produces potentiation of the second response as compared to the first (paired pulse potentiation, PPP) or depression (paired-pulse depression, sometimes also referred tc as habituation). Previous studies on the effects of APB on habituation and PPP in the hippocampal for-mation(l'i) were carried out before differences between lateval and medial perforant pathis were reported (4, 18) , and before the discovery of a new antagonist, icynurenic acid, that appears to block perforant path postsynaptic receptors (14) . For these rea.~o s, a reexamination of the effects of APB on perforant path was u.ndertakonO.l9). App~lication of L)-APB causes a reducedon in lateral pertorant path responses, but also an increase i~the percent PPP of these responses. The effect does not result simply from reducing --esponse size, because the amount of potentiation of matched first re-sponses increases, and also because APB reduces the potentiated response provt~rtionately less th-an , comparable first response. A similar effect is seen by decreas'. .r-xtracellular ca~iumj which would deera-ase presynaptlc release. * Reducing la,-rl perforant path reasponses with kynurenic acid, which apparently acts on postsynaptic sites, does not have a similar effect on PPP; although the synaptic responses are reduced in amplitude, there Is no change in the percent PPP. These results may Indicate a presynaptic action of APBs possibly mediated via an effect on presynaptic * calcium availability, One possible mechanism is suggested by the findings that Chloride ion affects APB-sensitive glutamte binding (2) , and that APB Increases a Chloride conductance in retina (5) . APB may increase chloride conductance presynaptically at the lateral perforant path, thereby clamping the presynaptic terminal near resting membrane potential. This could then decrease the voltage-dependant Calcium ion influx(n therefore decrease presynaptic release) evoked by lateral perforant path fiber activation by decreasing the amount of presynaptic terminal depolarization.
In a study just completed, the effects of different synaptic antagonists on paired *pulse depression o! medial perforant path responses were examined in rat hippocam-pal slices (20) . Kynurenic acid reduces the first and second responses to paired stimulation in the same proportions, having, therefore, no effect on the percent paired-pulse depression.
Thi-s contrasts with the effects of the potent medial perforant path antagonist baclof en (20) , which does not have the same net ef fect on the first and second responses to paired stimulation, and decreases the percent paired-pulse depression. lFurthermoret at doses that reduced the medial perforant path response by halfI the paired-pulse plasticity changed from depression to potentiation. A similar effect on medial perforant path paire-d-puls-e plasticity is produced by decreasing the extratellular calcium concentration. Thes-e results suggest that baclofen reduces the synaptic response po*s ynaptically, possibly via reducing presynaptic calciu'm availability, whereas kyriurenate acts postsynaptleýAiy. Ibis hypothesis was tested further using adenosine, which Maq been found to be a potent antagonist at other hippocampal pathways(21) and * probably ams prisvv~r~y via a presynaptic mechaailsm. Adenosine was also found to be a potent antagonist of medial perforent path responses, with effects on paired-puls-e plasticity similar to those of baclofen. F~inally# we examined the effects of the most potent of the PzDA derivatives, L)-CB-P",,DA, which we believe is a postsynaptic antagonist. Like kynurenate,p~t',B-PzDA blocks the synaptic response without changing the %PPP. Thiese results clearly show that precise selection of antagonists can be used to act on only certain aspects of hipopocampal synaptic transmission. A striking change in synaptic efficacy along hippocampal pathways can be produced by delivering brief trains of high frequency stimulation (22) . The resulting increase in synaptic effieacy may last for many hours, or even weeks and has been termed long-terin potentiation (LTP) (23) . LTP has been proposed to be a synaptic analogue of memory. "There is evidence for NMDA receptors throughout the CNS (3, 24) , but their functional significance remains unclear, especially since the potent NMDA antagonists have not yet been found to block any identified central synaptic pathway !n the vertebrate brain. As mentioned above, one of the highest concentrations of NMDA receptors was found !n .. stratum radiatunm of hijpoeamjAi subfieid CAI. Recently, D,JL(±)-APS was reported to " .. * interfere with the induction of LTP it, the hippocampus (13, 25, 26) . We have eox&mined the involvement of NMDA receptors in UTP using tAP5, tAPl (DL-(,)-2-,amino-7-phosphono-"heptanoic acid) and other longer-and shorter-chain phosphoro acidic amino acid analogues(27). Thesc compounds were chosen because NMDA receptors show a distinctive spectrum of sensitivity to this seder. of stru-,turai'y re'sted drup(2,21; -grid 4 .see Fig. 5 ).
We havG tested these analogues against NMDA response in the hippocampus and 4* 13.
also examined their effects on LTP of synaptic responses. The high frequency stimulation we used elicited near maximal LTP under control conditions. Under control conditions, a second high frequncy stimulation produced little further LTP. To control for variations in the maximal amount of LTP that could be elicited in different slices, LTP was quantified by comparing the amount of LTP obtained by a first high frequency stimulation in the presence of a test compound to the amount of LTP produced by stimulation after the drug was washed out. The 5-and 7-phosphono compounds (±AP5 and W±AP) blocked NMDA depolarizations and also reversibly prevented the induction of LTP of Schaffer collateral responses. After these drugs were washed out, LTP could be elicited. These compounds did not reduce responses to applied KA or QA and did not affect unpotentiated synaptic response amplitude, however. APB and other closely related phosphonates MAP6 (D,L-(*)-2-amino-6-phosphonohexanoie acid) and fAP8 (D,L-(i)-2-amino-8-phosphonooctanoic acid) did not block either amino acid excitant responses or LTP (Fig. 5) . This pharmacological profile is diagnostic for NMDA receptors (2, 24 ) and these results demonstrate that NMDA receptors present in the hippocampus are identical to those found elsewhere. Furthermore, although these receptors are not necessary for normal synapti tranqmission, they are involved in the initiation of long-term synaptic Splasticity.
T'lV Is the first clear evidence for the involvement of NMDA receptors in brain svnptic transmission.
CONCLUI014
Research o-e;. the first yeza has focused on the definition of .idec amino acid recepto.' types and their properties in the CNS. Phosphonle acid derivativs have proven " to be among the mn"s+ potert sntalrorists of excitatory synaptic transmission. With minor adjustments in their struecur.,~ they will block synaptic transmission or interfere with the dvvolupment of oynaptic plastiii.iy at br+ain pathways. New compotmds are also becoming available which are more gneral antagonists and which have the ability to generally depress braini aetl•ity. Piperazine derivatives are the most potent general antagonists yet ieenkified. L-APB, howeve-, is the most potent specific totrtag-bist of acidic amino acids knowit.
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